Navigation Links
Doctors' Guide to Cancer Drugs May Need Revising
Date:2/17/2009

Physicians often rely on outdated data when making 'off-label' decisions, study says

MONDAY, Feb. 16 (HealthDay News) -- Doctors may not always have complete or clear information when they prescribe cancer medications for uses beyond what the drugs have been approved for, a new study finds.

According to the report, published in the Feb. 17 online issue of Annals of Internal Medicine, the online and hard-copy resource used by oncologists and pharmacists, known as the compendia, does not always contain clear or updated information on using medications for "off-label" purposes, such as treating diseases other than those approved by the U.S. Food and Drug Administration.

Doctors and pharmacists often rely on the compendia for off-label dosage information, making it an authoritative source, in some instances, when a question arises about whether insurance will cover a drug for off-label use.

But the researchers found a lack of systematic methods to ensure the compendia information is regularly reviewed or updated.

"Oncologists and pharmacists use the compendia to guide choice of drugs for cancer patients that are not FDA-approved for use in that patient's disease -- an example would be bevacizumab, or Avastin, for brain cancer," the study's lead investigator, Dr. Amy Abernethy, an oncologist at Duke University, said in a news release issued by the school. "Bevacizumab is approved for use in diseases such as colorectal and lung cancer; it is not FDA-approved for brain tumors. But we have evidence that suggests it could be effective in this population, including peer-reviewed studies."

Abernethy's team, from the Duke Comprehensive Cancer Center, also found inconsistencies and confusion in how some commonly used compendia presented information and updated it. Some entries, for example, were more detailed than others, and information was presented in different ways for different drugs.

"Our study found that there are some limitations in the way the compendia are currently presented, and there are opportunities to improve the system," Abernethy said. "Determining how to improve it will be the next step for policymakers."

More information

The U.S. Food and Drug Administration has more about prescription drugs.



-- Kevin McKeever



SOURCE: Duke University, news release, Feb. 16, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Many Hospital Patients Cant ID Their Doctors
2. Wanted: Pioneer IVF Babies Bay Area Fertility Doctors Launch National Search for First IVF Babies Born 25 Years Ago
3. Doctors Fear Patients Not Filling Prescriptions
4. Unbelievable Lack Of Marketing Knowledge Forces Doctors To Quit Practice.
5. Doctors of Optometry Cheer Obamas Call to Action on Childrens Vision
6. Consumer Advocates Call on Legislature to Support Governors Ban on Pharmaceutical Gifts to Doctors
7. Study shows that primary care doctors miss opportunities to recommend colon cancer screening
8. Columbia Doctors, the Physicians and Surgeons of Columbia University Select MxSecure, Inc., as Their Medical Transcription Vendor of Choice
9. AOA Doctors of Optometry Partner With FDA and Other Industry Leaders to Develop New Measures to Better Protect Contact Lens Wearers
10. New Web Site Connects Patients with Experienced Doctors
11. Eye Doctors Offer Advice for Viewers on Super Bowl 3D Ads
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Doctors' Guide to Cancer Drugs May Need Revising
(Date:1/22/2017)... , ... January 22, 2017 , ... Zifam Pinnacle, an ... the world, recently met with big-name retail buyers at the January ECRM Trade Show ... efficacy and uses the utmost safety standards in all of its creations to help ...
(Date:1/22/2017)... ... January 22, 2017 , ... Medical lab testing ... Often the results of a simple test will take days to arrive to the ... Now offers customers direct access to their lab tests, bypassing the cost and delay ...
(Date:1/21/2017)... ... ... Salveo for life, a company that distributes an effervescent lime-flavored drink called ... part of its presence to expand its market reach. , Using a formula developed ... nasty toxins as a result of drinking alcohol, eliminating those toxins quickly, whilst supporting ...
(Date:1/21/2017)... ... January 21, 2017 , ... Seamild, the largest manufacturer of oats ... of its owner and founder. As Oat is recognized globally as one of the ... personally as he believes it is a move to sow the seed of good ...
(Date:1/21/2017)... Santa Barbara, CA (PRWEB) , ... January 21, ... ... through its Director of Alumni Relations, Dianne Travis-Teague, the electrifying line-up of events ... enlivening festivities for alumni, family, friends, and community. “Coming Home 2017” will ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... NEW YORK , Jan. 19, 2017 ... report provides understanding and access to partnering deals and ... - Trends in partnering deals - Top deals ... sector, stage of development, technology type The report ... agreements entered into by the world,s leading healthcare companies. ...
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast ... VNDA ) today announced it will release results for the fourth ... closes. ... will host a conference call at 4:30 PM ET on Wednesday, ... and full year 2016 financial results and other corporate activities. To ...
(Date:1/19/2017)... Jan. 19, 2017 This report on the ... future scenario of the global market. Large number of ... Severe chronic constipation is a major side effect of ... Hence, novel targeted therapy has been prescribed to treat ... of targeted medicines, and growing awareness about the therapy ...
Breaking Medicine Technology: